Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis

Marie Yeo, Dong Kyu Kim, Hee Jin Park, Tae Young Oh, Jang Hee Kim, Sung Won Cho, Young Ki Paik, Ki Baik Nahm

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Though ulcerative colitis (UC)-associated colon cancer develops from dysplastic lesions caused by chronic inflammation, the specific mechanistic link between chronic inflammation and carcinogenesis in colon has not been integrated into molecular understanding. We therefore established an experimental animal model for colitic cancer, and used proteomic analysis, based on 2-DE and MALDI-TOF MS, to identify proteins involved in colitic cancer. In our model, 6-week-old C57BL/6J mice were exposed to 15 cycles of dextran sodium sulfate (DSS), with each cycle consisting of 0.7% DSS for 1 week followed by distilled water for 10 days. Colorectal tumors developed in 22 of 24 mice (91.6%), with a tumor multiplicity of 1.727 per tumor-bearing mouse. Comparative 2-DE analysis showed that 38 protein spots were differentially expressed in colon tumors and normal colon. We identified 27 of these proteins, including GRP94, HSC70, enolase, prohibitin, and transgelin. The reduction of transgelin expression in mouse colon tumors was confirmed by Western blotting and immunohistochemistry. We also found that transgelin expression was significantly reduced in human colon tumors compared with adjacent non-tumorous tissues. In conclusion, these results suggest that loss of transgelin could be a candidate for biomarker of repeated colitis-associated colon cancer.

Original languageEnglish
Pages (from-to)1158-1165
Number of pages8
JournalProteomics
Volume6
Issue number4
DOIs
Publication statusPublished - 2006 Feb 1

Fingerprint

Ulcerative Colitis
Tumors
Colon
Carcinogenesis
Neoplasms
Dextran Sulfate
Colonic Neoplasms
Bearings (structural)
Proteins
Phosphopyruvate Hydratase
Inflammation
Biomarkers
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Colitis
transgelin
Inbred C57BL Mouse
Animals
Proteomics
Colorectal Neoplasms
Tissue

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology

Cite this

Yeo, M., Kim, D. K., Park, H. J., Oh, T. Y., Kim, J. H., Cho, S. W., ... Nahm, K. B. (2006). Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. Proteomics, 6(4), 1158-1165. https://doi.org/10.1002/pmic.200500390
Yeo, Marie ; Kim, Dong Kyu ; Park, Hee Jin ; Oh, Tae Young ; Kim, Jang Hee ; Cho, Sung Won ; Paik, Young Ki ; Nahm, Ki Baik. / Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. In: Proteomics. 2006 ; Vol. 6, No. 4. pp. 1158-1165.
@article{32a659e482d743d9805aa36acd165671,
title = "Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis",
abstract = "Though ulcerative colitis (UC)-associated colon cancer develops from dysplastic lesions caused by chronic inflammation, the specific mechanistic link between chronic inflammation and carcinogenesis in colon has not been integrated into molecular understanding. We therefore established an experimental animal model for colitic cancer, and used proteomic analysis, based on 2-DE and MALDI-TOF MS, to identify proteins involved in colitic cancer. In our model, 6-week-old C57BL/6J mice were exposed to 15 cycles of dextran sodium sulfate (DSS), with each cycle consisting of 0.7{\%} DSS for 1 week followed by distilled water for 10 days. Colorectal tumors developed in 22 of 24 mice (91.6{\%}), with a tumor multiplicity of 1.727 per tumor-bearing mouse. Comparative 2-DE analysis showed that 38 protein spots were differentially expressed in colon tumors and normal colon. We identified 27 of these proteins, including GRP94, HSC70, enolase, prohibitin, and transgelin. The reduction of transgelin expression in mouse colon tumors was confirmed by Western blotting and immunohistochemistry. We also found that transgelin expression was significantly reduced in human colon tumors compared with adjacent non-tumorous tissues. In conclusion, these results suggest that loss of transgelin could be a candidate for biomarker of repeated colitis-associated colon cancer.",
author = "Marie Yeo and Kim, {Dong Kyu} and Park, {Hee Jin} and Oh, {Tae Young} and Kim, {Jang Hee} and Cho, {Sung Won} and Paik, {Young Ki} and Nahm, {Ki Baik}",
year = "2006",
month = "2",
day = "1",
doi = "10.1002/pmic.200500390",
language = "English",
volume = "6",
pages = "1158--1165",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "4",

}

Yeo, M, Kim, DK, Park, HJ, Oh, TY, Kim, JH, Cho, SW, Paik, YK & Nahm, KB 2006, 'Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis', Proteomics, vol. 6, no. 4, pp. 1158-1165. https://doi.org/10.1002/pmic.200500390

Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. / Yeo, Marie; Kim, Dong Kyu; Park, Hee Jin; Oh, Tae Young; Kim, Jang Hee; Cho, Sung Won; Paik, Young Ki; Nahm, Ki Baik.

In: Proteomics, Vol. 6, No. 4, 01.02.2006, p. 1158-1165.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis

AU - Yeo, Marie

AU - Kim, Dong Kyu

AU - Park, Hee Jin

AU - Oh, Tae Young

AU - Kim, Jang Hee

AU - Cho, Sung Won

AU - Paik, Young Ki

AU - Nahm, Ki Baik

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Though ulcerative colitis (UC)-associated colon cancer develops from dysplastic lesions caused by chronic inflammation, the specific mechanistic link between chronic inflammation and carcinogenesis in colon has not been integrated into molecular understanding. We therefore established an experimental animal model for colitic cancer, and used proteomic analysis, based on 2-DE and MALDI-TOF MS, to identify proteins involved in colitic cancer. In our model, 6-week-old C57BL/6J mice were exposed to 15 cycles of dextran sodium sulfate (DSS), with each cycle consisting of 0.7% DSS for 1 week followed by distilled water for 10 days. Colorectal tumors developed in 22 of 24 mice (91.6%), with a tumor multiplicity of 1.727 per tumor-bearing mouse. Comparative 2-DE analysis showed that 38 protein spots were differentially expressed in colon tumors and normal colon. We identified 27 of these proteins, including GRP94, HSC70, enolase, prohibitin, and transgelin. The reduction of transgelin expression in mouse colon tumors was confirmed by Western blotting and immunohistochemistry. We also found that transgelin expression was significantly reduced in human colon tumors compared with adjacent non-tumorous tissues. In conclusion, these results suggest that loss of transgelin could be a candidate for biomarker of repeated colitis-associated colon cancer.

AB - Though ulcerative colitis (UC)-associated colon cancer develops from dysplastic lesions caused by chronic inflammation, the specific mechanistic link between chronic inflammation and carcinogenesis in colon has not been integrated into molecular understanding. We therefore established an experimental animal model for colitic cancer, and used proteomic analysis, based on 2-DE and MALDI-TOF MS, to identify proteins involved in colitic cancer. In our model, 6-week-old C57BL/6J mice were exposed to 15 cycles of dextran sodium sulfate (DSS), with each cycle consisting of 0.7% DSS for 1 week followed by distilled water for 10 days. Colorectal tumors developed in 22 of 24 mice (91.6%), with a tumor multiplicity of 1.727 per tumor-bearing mouse. Comparative 2-DE analysis showed that 38 protein spots were differentially expressed in colon tumors and normal colon. We identified 27 of these proteins, including GRP94, HSC70, enolase, prohibitin, and transgelin. The reduction of transgelin expression in mouse colon tumors was confirmed by Western blotting and immunohistochemistry. We also found that transgelin expression was significantly reduced in human colon tumors compared with adjacent non-tumorous tissues. In conclusion, these results suggest that loss of transgelin could be a candidate for biomarker of repeated colitis-associated colon cancer.

UR - http://www.scopus.com/inward/record.url?scp=33644508356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644508356&partnerID=8YFLogxK

U2 - 10.1002/pmic.200500390

DO - 10.1002/pmic.200500390

M3 - Article

C2 - 16402363

AN - SCOPUS:33644508356

VL - 6

SP - 1158

EP - 1165

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 4

ER -